Itopride
- Generic Name
- Itopride
- Drug Type
- Small Molecule
- Chemical Formula
- C20H26N2O4
- CAS Number
- 122898-67-3
- Unique Ingredient Identifier
- 81BMQ80QRL
- Background
Itopride is a dopamine D2 antagonist with acetylcholinesterase inhibitory actions.
- Indication
Investigated for use/treatment in gastrointestinal diseases and disorders (miscellaneous).
- Associated Conditions
- Abdominal Pain, Anorexia, Dyspepsia, Functional Dyspepsia, Gastroenteritis, Nausea, Nausea and vomiting, Vomiting, Abdominal bloating, Pyrosis, Stomach discomfort
Efficacy of Prokinetics With Split Dose of PEG in Morning Colonoscopic Bowel Preparation
- First Posted Date
- 2012-01-20
- Last Posted Date
- 2012-04-03
- Lead Sponsor
- Inje University
- Target Recruit Count
- 152
- Registration Number
- NCT01513096
- Locations
- 🇰🇷
Haeundae Paik Hospital, Inje University School of Medicine, Busan, Korea, Republic of
Study to Evaluate the Role of Itopride HCI in Patients With Irritable Bowel Syndrome With Predominant Constipation
- Conditions
- Irritable Bowel Syndrome
- Interventions
- First Posted Date
- 2009-12-07
- Last Posted Date
- 2013-06-18
- Lead Sponsor
- Abbott
- Target Recruit Count
- 268
- Registration Number
- NCT01027260
- Locations
- 🇵🇰
Site Reference ID/Investigator# 21441, Karachi, Pakistan
🇵🇰Site Reference ID/Investigator# 6130, Lahore, Pakistan
🇵🇰Site Reference ID/Investigator# 5870, Karachi, Pakistan
Randomized Controlled Trial of Acupuncture for Functional Dyspepsia
- First Posted Date
- 2008-01-24
- Last Posted Date
- 2011-11-09
- Lead Sponsor
- Chengdu University of Traditional Chinese Medicine
- Target Recruit Count
- 720
- Registration Number
- NCT00599677
- Locations
- 🇨🇳
Chengdu University of TCM, Chengdu, Sichuan, China
Efficacy and Safety of Itopride vs Placebo in Heartburn
- Conditions
- Heartburn
- First Posted Date
- 2006-09-29
- Last Posted Date
- 2017-02-09
- Lead Sponsor
- Forest Laboratories
- Target Recruit Count
- 48
- Registration Number
- NCT00382577
- Locations
- 🇺🇸
The Oklahoma Foundation for Digestive Research, Oklahoma City, Oklahoma, United States
Effects of Itopride on Gastric Motor and Sensory Functions in Healthy Volunteers
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2006-08-30
- Last Posted Date
- 2017-02-09
- Lead Sponsor
- Forest Laboratories
- Target Recruit Count
- 45
- Registration Number
- NCT00370110
- Locations
- 🇺🇸
Mayo Clinic College of Medicine, Rochester, Minnesota, United States
Itopride Hydrochloride in Diabetes: Effects on Gastric Emptying and Glycemia
- First Posted Date
- 2006-08-30
- Last Posted Date
- 2017-02-09
- Lead Sponsor
- Forest Laboratories
- Target Recruit Count
- 25
- Registration Number
- NCT00370084
- Locations
- 🇦🇺
University of Adelaide, Department of Medicine, Adelaide, South Australia, Australia
A Study to Evaluate the Effect of a Medicine on Gastric Functions in Healthy Volunteers.
- Conditions
- Healthy Volunteers
- First Posted Date
- 2006-03-29
- Last Posted Date
- 2011-03-23
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 45
- Registration Number
- NCT00308399
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Itopride in Functional Dyspepsia:a Dose Finding Study
- Conditions
- Functional Dyspepsia
- First Posted Date
- 2006-01-04
- Last Posted Date
- 2006-05-04
- Lead Sponsor
- Royal Adelaide Hospital
- Target Recruit Count
- 500
- Registration Number
- NCT00272103
- Locations
- 🇩🇪
University Hospital Essen, Essen, Germany
Effect of Itopride, on Symptoms of Functional Dyspepsia, Such as Indigestion, Bloating, Inability to Finish a Meal
- Conditions
- Dyspepsia
- First Posted Date
- 2005-06-01
- Last Posted Date
- 2017-02-08
- Lead Sponsor
- Forest Laboratories
- Target Recruit Count
- 500
- Registration Number
- NCT00112177
- Locations
- 🇨🇦
Monique Giguère, Ph.D. - Programs Director, Mont-Saint-Hilaire, Quebec, Canada
Long-Term Safety and Efficacy of Itopride Hydrochloride (HCl) in Patients Suffering From Functional Dyspepsia
- Conditions
- Dyspepsia
- First Posted Date
- 2005-06-01
- Last Posted Date
- 2017-02-08
- Lead Sponsor
- Forest Laboratories
- Target Recruit Count
- 466
- Registration Number
- NCT00112203
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.